Skip to content

Care EcoSystem: Ochsner Health System

The Dementia Care EcoSystem: The Feasibility of a Care Management Program Addressing Healthcare Quality, Access, and Cost for Patients With Dementia and Their Caregivers

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03916718
Enrollment
290
Registered
2019-04-16
Start date
2019-02-26
Completion date
2022-05-01
Last updated
2023-03-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dementia

Brief summary

1. To determine the feasibility and acceptability of the Care Ecosystem program in the Ochsner clinical setting. 2. To assess the effect of the Care Ecosystem program on health care cost and quality care quality as measured by primary outcome variables. * Adapted from the Care Ecosystem, memory.ucsf.edu/Care-Ecosystem

Interventions

BEHAVIORALCare EcoSystem

This is a care management program and health care outcomes feasibility study utilizing the dementia Care Ecosystem (CE) program developed at UCSF and tailored to high need Ochsner PWD (patient with dementia) and their CGs (caregivers). Dyads (CGs and PWD) will receive a tailored clinical assessment addressing dementia severity, PWD and CG needs, education/strategies to management common dementia issues, medical issues and medication reconciliation, caregiver wellness strategies, linkages to community-based resources, advance care planning, education about the risk of ED and hospitalization, and care coordination with other specialties. Dyads will be followed on a monthly basis to monitor needs, provide support, and problem solve issues.

Sponsors

Ochsner Health System
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
55 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Male or female ≥55 years of age at baseline * Probable dementia diagnosis as evidenced by one or more of the following criteria: * Dementia listed on medical record problem list as of January 1, 2015 or later, or, in the opinion of the referring provider has dementia * Prescribed with any of the following: donepezil, memantine, galantamine HBR, rivastigmine, or tartrate; or, in the opinion of the referring provider, could take such medication * Lives in community

Exclusion criteria

* Documented history of Multiple Sclerosis, ALS, Traumatic Brain Injury, Huntington's Disease, Schizophrenia, Bipolar Disorder, or current Substance Abuse Disorder * Lives in a nursing home or assisted living facility * Unable to complete monthly telehealth or phone visits

Design outcomes

Primary

MeasureTime frameDescription
Rate of ED and Hospital Admissionsthrough study completion, an average of 1 yearCost
Quick Dementia Rating Scale (QDRS)through study completion, an average of 1 yearConstruct: Dementia severity Sum total score Normal 0-1 Mild cognitive impairment 2-5 Mild dementia 6-12 Moderate dementia 13-20 Severe dementia 20-30
Quality of Life in Dementia (QUALI-DEM)through study completion, an average of 1 yearConstruct: Dementia patient quality of life Subscales Care Relationship (0-9) Positive Affect (0-12) Negative Affect (0-6) Restless Tense Behavior (0-9) Social Relations (0-9) Social Isolation (0-9) Higher scores= more of that behavior
Zarit Caregiver Burden Scale- Short Formthrough study completion, an average of 1 yearConstruct: Family/Caregiver quality of life Sum total score 0-48, higher scores indicate more burden

Secondary

MeasureTime frame
Rate of UTIsthrough study completion, an average of 1 year
Rate of medication changethrough study completion, an average of 1 year
Rate of Fallsthrough study completion, an average of 1 year

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026